Cintas Finite-Lived Intangible Assets - Expected Amortization Expense (Year One) increased by 4.4% to $84.18M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 0.9%, from $83.43M to $84.18M. This increase may warrant attention — for this metric, lower values are generally preferred.
Higher values indicate a larger near-term drag on reported earnings due to previous acquisition activity.
This represents the projected non-cash expense related to the amortization of finite-lived intangible assets for the upc...
Companies with high M&A activity in the medical device space typically report significant annual amortization expenses.
finite_lived_intangible_assets_amortization_year_1| Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $79.28M | $83.35M | $87.55M | $71.83M | $75.02M | $80.28M | $72.05M | $78.07M | $83.43M | $75.52M | $80.63M | $84.18M |
| QoQ Change | — | +5.1% | +5.0% | -18.0% | +4.4% | +7.0% | -10.3% | +8.4% | +6.9% | -9.5% | +6.8% | +4.4% |
| YoY Change | — | — | — | -9.4% | -10.0% | -8.3% | +0.3% | +4.1% | +3.9% | +4.8% | +3.3% | +0.9% |